Suppr超能文献

相似文献

1
Soluble VE-cadherin as a biomarker of response to immunotherapy by anti-PD1 in metastatic melanoma.
Br J Cancer. 2025 Jun;132(10):863-865. doi: 10.1038/s41416-025-03026-0. Epub 2025 Apr 18.
2
Systemic treatments for metastatic cutaneous melanoma.
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
3
Unlocking the power of immune checkpoint inhibitors: Targeting YAP1 reduces anti-PD1 resistance in skin cutaneous melanoma.
Br J Pharmacol. 2025 Aug;182(16):3903-3922. doi: 10.1111/bph.70052. Epub 2025 May 5.
5
Common inherited loss-of-function mutations in the innate sensor NOD2 contribute to exceptional immune response to cancer immunotherapy.
Proc Natl Acad Sci U S A. 2025 Jul 15;122(28):e2314258122. doi: 10.1073/pnas.2314258122. Epub 2025 Jul 7.
6
Sex-specific cytokine signatures as predictors of anti-PD1 therapy response in non-small cell lung cancer.
Front Immunol. 2025 Jun 16;16:1583421. doi: 10.3389/fimmu.2025.1583421. eCollection 2025.
7
Plasmacytoid Dendritic Cells Mediate CpG-ODN-induced Increase in Survival in a Mouse Model of Lymphangioleiomyomatosis.
Am J Respir Cell Mol Biol. 2024 Nov;71(5):519-533. doi: 10.1165/rcmb.2023-0410OC.
8
WITHDRAWN: Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma.
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD005413. doi: 10.1002/14651858.CD005413.pub3.
9
Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma.
Cochrane Database Syst Rev. 2007 Jan 24(1):CD005413. doi: 10.1002/14651858.CD005413.pub2.

本文引用的文献

3
The in vitro dynamics of pseudo-vascular network formation.
Br J Cancer. 2024 Aug;131(3):457-467. doi: 10.1038/s41416-024-02722-7. Epub 2024 Jun 20.
4
Late stage melanoma is hallmarked by low NLGN4X expression leading to HIF1A accumulation.
Br J Cancer. 2024 Aug;131(3):468-480. doi: 10.1038/s41416-024-02758-9. Epub 2024 Jun 20.
5
Biomarkers for Outcome in Metastatic Melanoma in First Line Treatment with Immune Checkpoint Inhibitors.
Biomedicines. 2023 Mar 1;11(3):749. doi: 10.3390/biomedicines11030749.
9
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.
N Engl J Med. 2015 Jul 2;373(1):23-34. doi: 10.1056/NEJMoa1504030. Epub 2015 May 31.
10
Evidence for post-translational processing of vascular endothelial (VE)-cadherin in brain tumors: towards a candidate biomarker.
PLoS One. 2013 Dec 16;8(12):e80056. doi: 10.1371/journal.pone.0080056. eCollection 2013.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验